4.5 Review

Reprint of: Recent Updates on Obesity Treatments: Available Drugs and Future Directions

期刊

NEUROSCIENCE
卷 447, 期 -, 页码 191-215

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuroscience.2020.08.009

关键词

obesity; associated-pathologies; pharmacotherapy; polypharmacology

资金

  1. Xunta de Galicia [2016-PG068, ED431G/05]
  2. Ministerio de Ciencia y Universidades - FEDER Program of EU [BFU2017-87721, SAF2015-71026-R, RTI2018-101840-B-I00, BFU2015-70454-REDT/Adipoplast]
  3. Atresmedia Corporacion

向作者/读者索取更多资源

In the last thirty years, obesity has reached epidemic proportions and is now regarded as a major health issue in contemporary society trending to serious economic and social burdens. The latest projections of the World Health Organization are alarming. By 2030, nearly 60% of the worldwide population could be either obese or overweight, highlighting the needs to find innovative treatments. Currently, bariatric surgery is the most effective way to efficiently lower body mass. Although great improvements in terms of recovery and patient care were made in these surgical procedures, bariatric surgery remains an option for extreme forms of obesity and seems unable to tackle obesity pandemic expansion. Throughout the last century, numerous pharmacological strategies targeting either peripheral or central components of the energy balance regulatory system were designed to reduce body mass, some of them reaching sufficient levels of efficiency and safety. Nevertheless, obesity drug therapy remains quite limited on its effectiveness to actually overcome the obesogenic environment. Thus, innovative unimolecular polypharmacology strategies, able to simultaneously target multiple actors involved in the obesity initiation and expansion, were developed during the last ten years opening a new promising avenue in the pharmacological management of obesity. In this review, we first describe the clinical features of obesity-associated conditions and then focus on the outcomes of currently approved drug therapies for obesity as well as new ones expecting to reach the clinic in the near future. This article is part of a Special Issue entitled: The Neuroscience of Energy Balance and Eating Behavior (C) 2020 IBRO. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据